Maximum Daily Dose of Enoxaparin (Clexane) for a 64-Year-Old Woman
For a 64-year-old woman, the maximum daily dose of enoxaparin depends on the clinical indication, but generally does not exceed 200 mg per day in divided doses for therapeutic anticoagulation, with specific caps of 100 mg per dose for the first two doses in acute coronary syndrome settings.
Context-Specific Maximum Dosing
For Acute Coronary Syndromes (ACS)
The most clearly defined maximum doses come from ACS guidelines 1, 2:
If age <75 years (applies to your 64-year-old patient):
- Initial: 30 mg IV bolus
- Followed by: 1 mg/kg subcutaneously every 12 hours
- Maximum cap: 100 mg for the first two doses only 1, 3, 1
- After the first two doses, no maximum cap is specified, but dosing continues at 1 mg/kg every 12 hours
Important calculation: For a typical 70 kg woman, this would be 70 mg twice daily (140 mg/day total) after the first two capped doses. For a 100 kg woman, it would be 100 mg twice daily (200 mg/day total).
For VTE Treatment (Non-ACS)
When treating venous thromboembolism 4, 5:
- Standard dose: 1 mg/kg subcutaneously every 12 hours
- No specific maximum cap is mentioned in guidelines for VTE treatment
- This means a 100 kg patient would receive 100 mg twice daily (200 mg/day)
Critical Renal Function Consideration
If creatinine clearance <30 mL/min 1, 2:
- Reduce to 1 mg/kg subcutaneously once daily (not twice daily)
- This effectively halves the total daily dose
- The 100 mg cap for first two doses in ACS still applies if age <75 years
Practical Maximum Doses by Weight
For your 64-year-old patient in the therapeutic setting:
| Patient Weight | Standard Dose (CrCl ≥30) | Renal Impaired (CrCl <30) |
|---|---|---|
| 50 kg | 50 mg BID (100 mg/day) | 50 mg once daily |
| 70 kg | 70 mg BID (140 mg/day) | 70 mg once daily |
| 90 kg | 90 mg BID (180 mg/day) | 90 mg once daily |
| 100 kg | 100 mg BID (200 mg/day) | 100 mg once daily |
Key Clinical Pitfalls
Age-related dosing error: At 64 years old, your patient is below the 75-year threshold, so she should receive the full dose with the IV bolus (if ACS indication). Do not mistakenly use the reduced elderly dosing 1, 3.
Renal function assessment is mandatory: Always calculate creatinine clearance using Cockcroft-Gault formula before initiating therapy. Failure to dose-reduce in renal impairment significantly increases bleeding risk 5, 6.
Duration limits: For ACS with fibrinolysis, treatment duration is typically up to 8 days or until revascularization 1, 3. This is not a "maximum dose" issue but prevents prolonged exposure.
Obesity considerations: While guidelines specify weight-based dosing up to very high weights, some evidence suggests monitoring anti-Xa levels in patients >150 kg may be prudent 7, 8, though this is not a formal guideline recommendation.
The 100 mg cap applies only to ACS patients <75 years for the first two doses - this is a bleeding risk mitigation strategy specific to the acute MI setting 1, 3. After two doses, continue with actual weight-based dosing without the cap.